Medication Adherence and Compliance Uncontrolled variables in psychiatric clinical drug trials According to Griswold, Murray & Corrado (2012), one troubling aspect of psychotropic drug clinical trials is the lack of controls for subjects' adherence to medication protocols. Psychiatric patients in particular have historically been noted to have relatively low levels of compliance. In general, "as drug dosages increase, treatment adherence decrease" because of intensification of symptoms, difficulty remembering dosages, and other issues

Drug culture at Temple U Transitioning from high school to college may be shocking to some individuals, but as they begin to get more comfortable with their environment, classes, and fellow students, one may realize that there are many similarities that carry over from their previous academic environment. One social structure that carries over from high school to college are the formation of social groups and cliques. The groups are usually

Drug Courts The Department of Justice of the United States of America, in order to cope with heavy work pressure, had to introduce a separate court for the sole purpose of dealing with criminal offenses committed by drug abusers and drug dependants. This concept has proved to be so successful that other countries of the world, including Australia, are now contemplating the introduction of a separate court for dealing with the

Trial by Jury One of the most controversial issues today in the area of criminal justice is that of the right of all defendants to a trial by jury their peers. While most arguments are for or against this right, careful consideration of specific issues and kinds of cases suggests that trial by jury should not be abolished entirely, but should not be an absolute right. The idea of trial by

Trial by Jury -- a right that must be upheld, in part One of the most controversial issues today in the area of criminal justice is that of the right of all defendants to a trial by jury of his or her peers. Often, as seen in the pairing of the essays of the noted defense attorney, media personality, and Harvard Legal scholar Alan Dershowitz against the words of Christie Davies,

It so happened that Russian doctor Karlov was trying to find patients for another clinical trial for an experimental drug, and Ershov fit the requirements to enter the study. "They told me the treatment was safe," says Ershov. "I trust my doctor completely." Like 90% of Karlov's other clinical-trial patients, he immediately signed the consent form (Lustgarten, p. 1). Russia is one of those countries that suffers from high